Grove Ventures recently hosted a Startup for Startup Healthcare community event, bringing together healthcare founders, operators, and industry leaders to discuss go-to-market strategies, commercialization challenges, and growth models in the U.S. healthcare market.
The event focused on practical go-to-market (GTM) strategies for healthcare startups navigating complex, multi-stakeholder systems, with an emphasis on U.S. market entry, pricing models, and commercialization frameworks.
The event opened with a keynote by Renana Ashkenazi, who described healthcare as a “multiplayer game,” where founders sell into interconnected systems rather than directly to hospitals.
She explained why a U.S.-first go-to-market strategy is often a strategic choice for healthcare startups, driven by market scale and clearer regulatory pathways.
Renana outlined a practical GTM mental model for healthcare companies, including:
She also cautioned founders against building businesses dependent on new CPT codes, noting that the American Medical Association approval process is slow, expensive, and high-risk. Instead, she encouraged teams to design GTM strategies around existing reimbursement codes.
The keynote was followed by a panel moderated by Anne Belkin-Amario, CMO at Navina, featuring Noam Keesom (Head of Marketing Strategy, Navina), Aaron Bours (CMO, Hyro), and Noa Silberklang (Head of EMEA, Rhino Federated Computing).
Panelists shared candid perspectives on:
The session concluded with a fireside chat between Renana Ashkenazi and Anne Belkin-Amario, offering a deeper discussion on real-world challenges and decision-making frameworks for scaling healthcare companies.
This Startup for Startup Healthcare event reflects Grove Ventures’ commitment to supporting founders through peer-driven learning, actionable insights, and hands-on guidance, particularly in regulated and technically complex sectors such as healthcare.
